Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

drchrono

Explore full profile

Develops the essential platform and services for modern medical practices to make care more informed, more interactive, and more personalized

Orlando, United StatesFounded 2009Biotech & Life Sciences
Valuation $0–100M Latest valuation · 2017
Headcount 100–500 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for drchrono and the history behind them.

About drchrono

DrChrono by EverHealth offers a comprehensive platform designed to modernize medical practices. The platform supports telehealth, electronic health records (EHR), practice management, medical billing, and revenue cycle solutions. It serves thousands of physicians and millions of patients, facilitating millions of patient appointments and processing billions of dollars in medical billing. The platform is highly extensible through a robust API and a marketplace of applications and services. DrChrono operates in the healthcare market, targeting medical practices and healthcare providers. The business model revolves around subscription fees for its software services and transaction fees for billing services. The company aims to make healthcare more informed, interactive, and personalized.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2009
Headquarters
Orlando, United States
Employees
124
Open positions
None listed
Dealroom signal
66.3/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices, Health Platform
Sector
Biotech & Life Sciences, Biotechnology, Patient Care, Tech for Medical Professionals, Medical Practice Management, Biotech and Pharma, Hard Tech, YC W11, DT and LS
Business model
SaaS
Client focus
b2b

Latest news

Press, funding announcements and product moves mentioning drchrono.

See all news

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONExit Nov 2021 $0 Evercommerce
DEBTDebt Jun 2021 $12M ORIX USA Corporation
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

drchrono website traffic

Latest recorded traffic for drchrono is 910K monthly website visits, up 21.3% over the last three months. drchrono's team declined 21.5% over the past year.

Latest monthly visits910K 3-month web change+21.3% 1-year team growth-21.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investors

21 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed8 investors entered at this stage

Series A2 investors entered at this stage

Series B and later7 investors entered at this stage

Other known investors4 additional known investors

  • Evercommerce
  • Oleg Koujikov
  • Rock Health Capital
  • Section Partners
Team profiled 35 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
6 countries with
team presence
🇺🇸 United States51.4%
🇮🇳 India25.7%
🇵🇭 Philippines12.9%
🇧🇷 Brazil5.7%
🇨🇦 Canada2.9%
Top 5 of 6 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about drchrono on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See drchrono’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.